Home Research COVID-19 Services Publications People Teaching Job Opening News Forum --> -->
Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●DMFold ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

BioLiP
Download all results in tab-seperated text for 72 receptor-ligand interactions, whose format is explained at readme.txt.
  • Hover over PDB to view the title of the structure. Click PDB to view the structure at the RCSB PDB database. Resolution -1.00 means the resolution is unavailable, e.g., for NMR structures.
  • Click Site # to view the binding site structure. Hover over Site # to view the binding residues.
  • Hover over Ligand to view the full ligand name. Click Ligand to view the 2D diagram and other detail information of the ligand.
  • Hover over EC number to view the full name of enzymatic activity.
  • Hover over GO terms to view all GO terms.
  • Hover over UniProt to view the protein name.

    • Sort results by
    << < 1 > >>
    Go to page

    # PDB
    (Resolution Å)     		Site # Ligand EC number GO terms UniProt PubMed Binding
    affinity
    1 7tf6:A (2.15) BS01 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    2 7tf6:A (2.15) BS02 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    3 7tf6:A (2.15) BS03 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    4 7tf6:A (2.15) BS04 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    5 7tf6:A (2.15) BS05 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    6 7tf6:A (2.15) BS06 GLN 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    7 7tf6:B (2.15) BS01 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    8 7tf6:B (2.15) BS02 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    9 7tf6:B (2.15) BS03 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    10 7tf6:B (2.15) BS04 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    11 7tf6:B (2.15) BS05 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    12 7tf6:B (2.15) BS06 GLN 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    13 7tf6:C (2.15) BS01 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    14 7tf6:C (2.15) BS02 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    15 7tf6:C (2.15) BS03 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    16 7tf6:C (2.15) BS04 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    17 7tf6:C (2.15) BS05 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    18 7tf6:C (2.15) BS06 GLN 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    19 7tf6:F (2.15) BS01 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    20 7tf6:F (2.15) BS02 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    21 7tf6:F (2.15) BS03 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    22 7tf6:F (2.15) BS04 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    23 7tf6:F (2.15) BS05 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    24 7tf6:F (2.15) BS06 GLN 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    25 7tf6:G (2.15) BS01 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    26 7tf6:G (2.15) BS02 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    27 7tf6:G (2.15) BS03 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    28 7tf6:G (2.15) BS04 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    29 7tf6:G (2.15) BS05 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    30 7tf6:G (2.15) BS06 GLN 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    31 7tf6:H (2.15) BS01 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    32 7tf6:H (2.15) BS02 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    33 7tf6:H (2.15) BS03 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    34 7tf6:H (2.15) BS04 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    35 7tf6:H (2.15) BS05 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    36 7tf6:H (2.15) BS06 GLN 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    37 7tf6:L (2.15) BS01 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    38 7tf6:L (2.15) BS02 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    39 7tf6:L (2.15) BS03 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    40 7tf6:L (2.15) BS04 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    41 7tf6:L (2.15) BS05 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    42 7tf6:L (2.15) BS06 GLN 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    43 7tf6:N (2.15) BS01 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    44 7tf6:N (2.15) BS02 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    45 7tf6:N (2.15) BS03 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    46 7tf6:N (2.15) BS04 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    47 7tf6:N (2.15) BS05 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    48 7tf6:N (2.15) BS06 GLN 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    49 7tf6:O (2.15) BS01 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    50 7tf6:O (2.15) BS02 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    51 7tf6:O (2.15) BS03 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    52 7tf6:O (2.15) BS04 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    53 7tf6:O (2.15) BS05 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    54 7tf6:O (2.15) BS06 GLN 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    55 7tf6:R (2.15) BS01 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    56 7tf6:R (2.15) BS02 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    57 7tf6:R (2.15) BS03 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    58 7tf6:R (2.15) BS04 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    59 7tf6:R (2.15) BS05 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    60 7tf6:R (2.15) BS06 GLN 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    61 7tf6:S (2.15) BS01 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    62 7tf6:S (2.15) BS02 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    63 7tf6:S (2.15) BS03 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    64 7tf6:S (2.15) BS04 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    65 7tf6:S (2.15) BS05 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    66 7tf6:S (2.15) BS06 GLN 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    67 7tf6:T (2.15) BS01 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    68 7tf6:T (2.15) BS02 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    69 7tf6:T (2.15) BS03 peptide 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    70 7tf6:T (2.15) BS04 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    71 7tf6:T (2.15) BS05 MG 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    72 7tf6:T (2.15) BS06 GLN 6.3.1.2 GO:0003824 ... E3VXC2 35778410
    Reference:
  • Chengxin Zhang, Xi Zhang, Peter L Freddolino, and Yang Zhang. BioLiP2: an updated structure database for biologically relevent ligand-protein interactions, Nucleic Acids Research, gkad630 (2023).
  • Jianyi Yang, Ambrish Roy, and Yang Zhang. BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions, Nucleic Acids Research, 41: D1096-D1103 (2013) (download the PDF file).

    • yangzhanglabumich.edu | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218